Child requiring repeated sho acting bronchodilators and what could be next line of management ?: (A) Methylxanthines, (B) Sho acting budesonide, (C) Oral prednisolone, (D) Montelukast
Answer is B. Ans. is 'b' i.e., Sho acting budesonide o Tolerance is a potential problem with b2-agonists. o So, b2 agonists should not be used on any regular schedule --> due to tolerance, bronchial hyperactivity not reduced on continous use. o It is advised that patients requiring regular medication should be treated with inhaled steroids and use of b2 agonist inhaler should be restricted to symptomatic relief of an acute attack.